FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4392011000001109: Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21587501000001110 Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21587601000001114 Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Is pack of Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has active ingredient Imipenem false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has active ingredient Cilastatin false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has manufactured dose form Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has VMP Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has specific active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has specific active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has dispensed dose form Powder for conventional release suspension for injection true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has specific active ingredient Imipenem monohydrate true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has specific active ingredient Cilastatin sodium true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) 1 vial Is a True Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start